Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2025-12-25 @ 9:02 PM
Study NCT ID:
NCT00447356
Status:
WITHDRAWN
Last Update Posted:
2013-05-13
First Post:
2007-03-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma
Sponsor:
Hackensack Meridian Health
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
E1697
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |